Effects of human immunodeficiency virus infection and detoxification time on anthropometric measurements and dietary intake of male drug addicts.
Anthropometric measurements and dietary intakes of male drug addicts (n = 62), infected (n = 23) or not infected (n = 39) with human immunodeficiency virus (HIV), who underwent two phases of detoxification (P1:15 d to 1 mo and P2: 5-6 mo) were assessed. Body weight, weight gain during detoxification, height, body mass index, and ideal body weight were measured. A prospective food-record questionnaire was compiled and energy and nutrient contents of ingested food were determined. Food intakes were compared with dietary recommendations for the Spanish population. At the time of the study, all patients had substantial weight gains, mostly in P1. Nutrient consumption was lower in P2 (energy, protein, and lipids) and in groups not infected with HIV. In P2, lipid intake was higher in the HIV-positive than in the HIV-negative group (P < 0.05, Student's t test). Moreover, an interactive effect of HIV by phase was shown for lipid intake (P = 0.04, two-way analysis of variance). Magnesium, folate, and vitamin E intakes were lower than recommended in nearly all patients. Energy, zinc, riboflavin, and vitamin B-6 intakes were lower than recommended or were borderline. HIV infection did not have a negative effect on anthropometric measurements or on nutrient intakes. The anthropometric assessment may suggest an adequate recovery of the indexes measured in all patients, which principally took place during P1. Measurement of nutrient intakes showed certain imbalances and deficits that should be corrected.
Varela
P
P
Instituto de Nutrición y Bromatología [Consejo Superior de Investigaciones Cientifícas (CSIC)], Universidad Complutense de Madrid (UCM), Spain.
Marcos
A
A
Ripoll
S
S
Santacruz
I
I
Requejo
A M
AM
D000328:Adult; D000886:Anthropometry; D004032:Diet; D002149:Energy Intake; D015658:HIV Infections / Q000150:complications* / Q000503:physiopathology; D006556:Heroin Dependence / Q000150:complications / Q000503:physiopathology / Q000534:rehabilitation*; D006801:Humans; D008297:Male; D008903:Minerals; D014815:Vitamins / Q000008:administration & dosage
D008903:Minerals; D014815:Vitamins